Nina Waldburger

668 citations
19 papers · 456 indexed · h-index 13
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)

In The Last Decade

Nina Waldburger

16 papers receiving 451 citations

Peers

Nina Waldburger
Comparison fields: 5 of 60
  • Molecular Biology 201
  • Oncology 149
  • Cancer Research 119
  • Hepatology 100
  • Pulmonary and Respiratory Medicine 94
Replace Tae Sung Ahn with:
Tae Sung Ahn South Korea
Ruoyu Shi China
Derek Yau China
Yasuo Koga Japan
Concetta Sgarra Italy
Warren Shih Canada
Valérie Dessirier France
Kazuma Ohtaka Japan
M W Büchler Switzerland
Jiachu Li China
Nina Waldburger relative to Tae Sung Ahn South Korea Tae Sung Ahn's profile →
Citations per field
00.5×1.6×
Tae Sung Ahn · 1×
Citations per year

Countries citing papers authored by Nina Waldburger

Since Specialization
Citations

This map shows the geographic impact of Nina Waldburger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Waldburger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Waldburger more than expected).

Fields of papers citing papers by Nina Waldburger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Waldburger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Waldburger. The network helps show where Nina Waldburger may publish in the future.

Co-authorship network of co-authors of Nina Waldburger

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Waldburger. A scholar is included among the top collaborators of Nina Waldburger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Waldburger. Nina Waldburger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 12
3 20
4 0
5 0
6 2
7 8
8 31
9 13
10 29
11 1
12 42
13 32
14 114
15 16
16 69
17 13
18 24
19 30

About Nina Waldburger

Nina Waldburger is a scholar working on Hepatology, Cancer Research and Oncology, having authored 19 papers that have together received 456 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Hepatology (100 citations), Cancer Research (119 citations) and Oncology (149 citations). Nina Waldburger has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Peter Schirmacher, Stéphanie Roessler, Thomas Longerich, Kai Breuhahn, Roland Penzel, Patricia T. Greipp, Kevin C. Halling, Sara M. Kloft‐Nelson, Long Jin and Lewis R. Roberts. Their work appears in journals such as PLoS ONE, Hepatology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026